Bloomberg Markets & Finance via Youtube


Sep.08 — AstraZeneca has paused research on its experimental coronavirus vaccine after a person who is participating in a clinical trial became ill. Bloomberg’s Riley Griffin reports on “Bloomberg Markets: China Open.”

READ ALSO  SE: The Tug-of-War Over TikTok